New clinical trial initiated on experimental vaccine to stop the spread of glioblastoma

Rush University Medical Center is part of a new clinical trial testing whether an experimental vaccine can help patients’ immune systems stop the spread of glioblastoma — an aggressive form of brain cancer with very few current treatment options.

Source link

Related posts

AI Can Better Predict Why Children Struggle at School


Editors' note: Ordinal vs dichotomous analyses of modified Rankin Scale, 5-year outcome, and cost of stroke


Beyond Football: Concussions Occur in All High School Sports


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy